SNU-387（人肝癌细胞）
CBP60214
询 价
SNU387细胞全景
产品描述
产品数据库
| I. General information | |
| Synonyms: | SNU-387 |
| Background: | SNU-387 was derived in 1990 by J.-G. Park and associates from a primary hepatocellular carcinoma taken from a Korean patient who had been treated by transcatheter arterial embolization with lipoidol plus a combination of doxorubicin and mitomycin-C. Tumor cells were initially cultured in ACL-4 medium supplemented with 5% heat-inactivated fetal bovine serum. After establishment, cultures were maintained in RPMI 1640 supplemented with 10% heat inactivated fetal bovine serum. |
| Species: | Homo sapiens, human |
| Tissue: | liver |
| Disease: | grade IV/V, pleomorphic hepatocellular carcinoma |
| Gender: | female, 41 years, Asian |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| Doubling Time: | 61 hrs |
| DNA Profile: | Amelogenin: X CSF1PO: 13,14 D13S317: 12 D16S539: 9 D5S818: 10,12 D7S820: 8,10 THO1: 7 TPOX: 8,9 vWA: 14,16 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS SNU-387完全培养基，# CBP60214M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | Blood Type O; Rh + |
| Comments: | Grossly, the original tumor was single nodular. Histologically, it was predominantly compact and minor trabecular type. The cultured cells contain a single nucleus. Hepatitis B virus (HBV) DNA was detected by Southern blot hybridization. HBV genomic RNA was not expressed. For more information, please contact us (4008-750-250). |
